Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Medical Oncology

• Publication date

  2013-04-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12032-013-0574-zPMID 23585015
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of stem-cell markers OCT-4 and CD133: important prognostic factors in papillary renal cell carcinoma.

  2012cited by this paper
• Stem cell markers aldehyde dehydrogenase type 1 and nestin expressions in renal cell cancer.

  2012cited by this paper
• Molecular Diagnostics

  2011cited by this paper
• High-level expression of stem cell marker CD133 in clear cell renal cell carcinoma with favorable prognosis.

  2011cited by this paper
• Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer

  2010cited by this paper
• Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability.

  2009cited by this paper
• Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.

  2009cited by this paper
• ALDH1 Expression Correlates with Favorable Prognosis in Ovarian Cancers

  2009cited by this paper
• Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.

  2009cited by this paper
• Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer

  2009cited by this paper
• IMP3 Predicts Aggressive Superficial Urothelial Carcinoma of the Bladder

  2008cited by this paper
• Widespread Nonhematopoietic Tissue Distribution by Transplanted Human Progenitor Cells with High Aldehyde Dehydrogenase Activity

  2008cited by this paper
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007cited by this paper
• Renal Cell Carcinoma: Prognostic Factors and Patient Selection

  2007cited by this paper
• Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys.

  2006cited by this paper
• Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells.

  2006cited by this paper
• Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells.

  2006cited by this paper
• Renal cell carcinoma

  2006cited by this paper
• Isolation of renal progenitor cells from adult human kidney.

  2005cited by this paper
• Phenotypic Characterization of Murine Primitive Hematopoietic Progenitor Cells Isolated on Basis of Aldehyde Dehydrogenase Activity

  2004cited by this paper
• Feedback inhibition of the retinaldehyde dehydrogenase gene ALDH1 by retinoic acid through retinoic acid receptor alpha and CCAAT/enhancer-binding protein beta.

  2000cited by this paper
• Feedback Inhibition of the Retinaldehyde Dehydrogenase GeneALDH1 by Retinoic Acid through Retinoic Acid Receptor α and CCAAT/Enhancer-binding Protein β*

  2000cited by this paper
• The Transcriptional Regulation of Human Aldehyde Dehydrogenase I Gene

  1995cited by this paper
• Retinal oxidation activity and biological role of human cytosolic aldehyde dehydrogenase.

  1992cited by this paper
• Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia.

  1984cited by this paper
• Electrophoretic and biochemical studies of human aldehyde dehydrogenase isozymes in various tissues.

  1980cited by this paper
• Renal cell carcinoma.

  1956cited by this paper

• Novel Anti-Cancer Stem Cell Compounds: A Comprehensive Review

  2024cites this paper
• The Significance of Aldehyde Dehydrogenase 1 in Cancers

  2024cites this paper
• Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets

  2023cites this paper
• N-Substituted 2-(Benzenosulfonyl)-1-Carbotioamide Derivatives Exert Antimicrobial and Cytotoxic Effects via Aldehyde Dehydrogenase Pathway: Synthesis, In Silico and In Vitro Studies

  2023cites this paper
• Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease.

  2023cites this paper
• The metabolic addiction of cancer stem cells

  2022cites this paper
• Drug-tolerant persister cells in cancer therapy resistance.

  2022cites this paper
• Alternative RNA splicing in stem cells and cancer stem cells: Importance of transcript-based expression analysis

  2021cites this paper
• The Most Common VHL Point Mutation R167Q in Hereditary VHL Disease Interferes with Cell Plasticity Regulation

  2021cites this paper
• The significance of Aldehyde dehydrogenase 1A1 expression in colorectal carcinoma

  2021cites this paper
• How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance

  2020cites this paper
• Targeting Strategies for Renal Cancer Stem Cell Therapy.

  2020cites this paper
• Characterization of ascites-derived aldehyde dehydrogenase–positive ovarian cancer stem cells isolated from Leghorn chickens

  2020cites this paper
• Identification of a novel cancer stem cell subpopulation that promotes progression of human fatal renal cell carcinoma by single-cell RNA-seq analysis

  2020cites this paper
• Immunohistochemical expression of ALHD1A1 in thyroid goiter and normal peritumor tissue around papillary thyroid carcinoma in a sample of Iraq patients

  2020cites this paper
• The clinical and prognostic impact of aldehyde dehydrogenase 1 in non-small cell lung cancer: a meta-analysis

  2020cites this paper
• Targeted Delivery of Therapeutics to Urological Cancer Stem Cells.

  2020cites this paper
• Arsenic-Induced Neoplastic Transformation Involves Epithelial-Mesenchymal Transition and Activation of the β-Catenin/c-Myc Pathway in Human Kidney Epithelial Cells.

  2019cites this paper
• Alternative splice variants of DCLK1 mark cancer stem cells, promote self‐renewal and drug‐resistance, and can be targeted to inhibit tumorigenesis in kidney cancer

  2018influential citation
• Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinoma

  2017cites this paper
• Immunohistochemical Expression of Aldehyde Dehydrogenase 1 (ALDH1) in Renal Cell Carcinomas

  2017influential citation
• Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3

  2016cites this paper
• Aldehyde Dehydrogenase 1 (aldh1) Genes In Cancer Clinical Prognosis Outcomes

  2016cites this paper
• The prognostic roles of ALDH1 isoenzymes in gastric cancer

  2016cites this paper
• The diagnostic significance of serum alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase activity in renal cell cancer patients.

  2016cites this paper
• Positive association between CD44 gene rs13347 C>T polymorphism and risk of cancer in Asians: a systemic review and meta-analysis

  2016cites this paper
• Chronic Oxidative Stress Increases Resistance to Doxorubicin-Induced Cytotoxicity in Renal Carcinoma Cells Potentially Through Epigenetic Mechanism

  2016cites this paper
• Malignant melanoma: diagnosis, treatment and cancer stem cells.

  2016cites this paper
• Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors

  2015cites this paper
• ALDH1A enzymes regulate retinoic acid homeostasis in a tissue specific manner: A model of how novel methods can unravel old unanswered questions

  2015cites this paper
• Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis

  2015cites this paper
• Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis

  2015cites this paper
• Syddansk Universitet miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations Gravgaard,

  2015cites this paper
• Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer

  2015cites this paper
• Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer

  2015cites this paper
• Importance of ALDH1A enzymes in determining human testicular retinoic acid concentrations

  2015cites this paper
• miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations

  2015cites this paper
• Distinct prognostic values of ALDH1 isoenzymes in breast cancer

  2015cites this paper
• DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma

  2014cites this paper
• ALDH Maintains the Stemness of Lung Adenoma Stem Cells by Suppressing the Notch/CDK2/CCNE Pathway

  2014cites this paper
• Cancer stem cells: emerging actors in both basic and clinical cancer research

  2014cites this paper
• Renal Cell Carcinoma Cancer Stem Cells as Therapeutic Targets

  2014cites this paper
• High ALDH1A1 expression correlates with poor survival in papillary thyroid carcinoma

  2014cites this paper
• World Journal of Stem Cells

  year unknowncites this paper
• Oncotargets and Therapy Dovepress Dovepress Prognostic Values of Aldehyde Dehydrogenase 1 Isoenzymes in Ovarian Cancer

  year unknowncites this paper